Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sun Biomedical Laboratories was a medical diagnostics company specializing in the development and manufacture of rapid, point-of-care drug-of-abuse testing products. The company's portfolio included proprietary technologies such as the Sun-Cup, Sun-Stick, and Sun-Dip, which provided integrated collection and testing solutions for clinical and workplace settings. Founded in 1993 and based in New Jersey, the company focused on simplifying the drug screening process through innovative device design that minimized sample handling and exposure. Their products were widely utilized across criminal justice, occupational health, and clinical toxicology sectors. In 2006, Sun Biomedical Laboratories was acquired by Inverness Medical Innovations for approximately $40 million in cash. Following the acquisition, its operations were integrated into the professional diagnostics division of Inverness, which later became Alere and was subsequently acquired by Abbott Laboratories.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sun Biomedical Laboratories.